FDA Turns Down Aerosol Migraine Drug

(MedPage Today) -- An inhalable aerosol formulation of dihydroergotamine (Levadex) for acute migraine treatment won't receive FDA approval until its manufacturer addresses the agency's concerns about the delivery device. (Source: MedPage Today Psychiatry)

MedWorm Sponsor Message: Have a look at The Psychiatry Daily, the new psychiatry portal powered by MedWorm, with all the latest psychiatry news and research updated daily.

via Original Article